You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Oncology
Aro Biotherapeutics Names Cancer Biologist McMahon and Protein Structure and Design Expert Swanson to its Scientific Advisory Board
Login
Username:

Password:


Related Headlines

Pfizer signs licensing agreement with Starna Therapeutics worth up to USD2.63bn

Ichnos Glenmark Innovation submits IND for ISB 2301 to treat solid tumours

Inhibrx updates clinical data for ozekibart (INBRX-109) in Ewing sarcoma

Onward Therapeutics closes Series B financing

Oncoinvent reports favourable interim safety results for Radspherin in phase 2 ovarian cancer trial

Apotex launches generic version of INLYTA in US market

Akeso submits sNDA for ivonescimab chemotherapy combination in first-line biliary tract cancer

CARsgen's satri-cel CAR-T product included in China's Commercial Health Insurance Innovative Drug List

IDEAYA Biosciences nominates IDE101 as development candidate, targeting CDKN2A-deficiency in solid tumours

Specialised Therapeutics' YONDELIS sarcoma therapy approved in Thailand

Rezolute's ersodetug meets primary endpoint in Phase 3 upLIFT study of tumour hyperinsulinism

PAI Pharma acquires Nexus Pharmaceuticals

Innovent Biologics presents preclinical data for IL-6/TL1A bispecific antibody IAR177

FDA grants Breakthrough Therapy designation to Clarity Pharmaceuticals' prostate cancer imaging agent

Guardant Health expands liquid biopsy test with AI-powered epigenomic applications

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026